0000898432-01-500374.txt : 20011026
0000898432-01-500374.hdr.sgml : 20011026
ACCESSION NUMBER: 0000898432-01-500374
CONFORMED SUBMISSION TYPE: 15-12G
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20011019
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: PHARMACEUTICAL RESOURCES INC
CENTRAL INDEX KEY: 0000878088
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 223122182
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 0930
FILING VALUES:
FORM TYPE: 15-12G
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-20605
FILM NUMBER: 1762171
BUSINESS ADDRESS:
STREET 1: ONE RAM RIDGE RD
CITY: SPRING VALLEY
STATE: NY
ZIP: 10977
BUSINESS PHONE: 9144257100
MAIL ADDRESS:
STREET 1: ONE RAM RIDGE RD
CITY: SPRING VALLEY
STATE: NY
ZIP: 10977
15-12G
1
pr158085.txt
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
Certification and Notice of Termination of Registration under Section 12(g) of
the Securities Exchange Act of 1934 or Suspension of Duty to File Reports
Under Sections 13 and 15(d) of the Securities Exchange Act of 1934
Commission File Number 1-10827
Pharmaceutical Resources, Inc.
--------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
One Ram Ridge Road, Spring Valley, New York 10977
(845) 425-7100
--------------------------------------------------------------------------------
(Address, including zip code, and telephone number, including area code, of
registrant's principal executive offices)
Common Stock Purchase Rights
--------------------------------------------------------------------------------
(Title of each class of securities covered by this Form)
Common Stock, $.01 Par Value
--------------------------------------------------------------------------------
(Titles of all other classes of securities for which a duty to file reports
under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i) [x ] Rule 12h-3(b)(1)(i) [ ]
Rule 12g-4(a)(1)(ii) [ ] Rule 12h-3(b)(1)(ii) [ ]
Rule 12g-4(a)(2)(i) [ ] Rule 12h-3(b)(2)(i) [ ]
Rule 12g-4(a)(2)(ii) [ ] Rule 12h-3(b)(2)(ii) [ ]
Rule 15d-6 [ ]
Approximate number of holders of record as of the certification or
notice date: None
Pursuant to the requirements of the Securities Exchange Act of 1934,
Pharmaceutical Resources, Inc. has caused this certification/notice to be signed
on its behalf by the undersigned duly authorized person.
Date: October 19, 2001 By: /s/ DENNIS J. O'CONNOR
--------------------------------------
Name: Dennis O'Connor
Title: Vice President-Chief Financial Officer